-
Top Takeaways From BMO's Specialty Pharma Day
Wednesday, July 1, 2015 - 1:13pm | 583Read More...In a report published Wednesday, BMO Capital Markets analyst David Maris discussed key takeaways from a day of meetings with several specialty pharmaceutical companies. Below are some of the highlights of notable presentations. Allergan PLC (NYSE: AGN): The company is planning to work...
-
Will Actavis Win Competition For Allergan's Affection?
Thursday, October 16, 2014 - 11:10am | 839Read More...Four pharmaceutical companies have been flirting with merger deals. Discussing the confusing courting, Barron’s called them the Bob & Carol & Ted & Alice of pharmaceuticals, referencing the sexy 1969 comedy-drama with the tag line “Consider the Possibilities.” In...
-
Market Wrap For May 14: Dow's Winning Streak Ends At Five Sessions
Wednesday, May 14, 2014 - 4:47pm | 2536Read More...U.S. stocks declined a day after the S&P 500 and Dow indices traded at record-high levels. Investors and traders were likely paying attention to the ten-year Treasury yield which hit 2.5258, the lowest level since late October. The bull market has paused, temporarily at least, until...
-
Citigroup On Watson Pharmaceuticals Following Healthcare Conference
Wednesday, March 2, 2011 - 10:27am | 134Read More...Citigroup has published a research report on Watson Pharmaceuticals (NYSE: WPI) after the company's participation in Citi's Healthcare conference. In the report, Citigroup writes "Paul Bisaro, WPI's President & CEO reiterated WPI's 2011 diluted EPS target of $3.85 to $4.15 and revenue of $4.2B...
